Kwang-Hoon Lee

Title: Kwang-Hoon Lee: Innovator in Cancer Treatment

Introduction

Kwang-Hoon Lee is a prominent inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of cancer treatment through his innovative research and development of novel antibodies.

Latest Patents

Kwang-Hoon Lee holds a patent for "Anti-TIGIT antibodies and uses thereof." This patent discloses a novel antibody that specifically binds to the tumor-immunosuppressant, TIGIT (T cell immunoglobulin and immunoreceptor tyrosine-based inhibitory motif [ITIM] domain). The patent includes a nucleic acid encoding the antibody, a vector, and a host cell containing the nucleic acid. It also outlines a method for producing the antibody and a pharmaceutical composition that contains the antibody as an active ingredient. The antibody and its pharmaceutical composition are particularly useful for the treatment of cancer or tumors.

Career Highlights

Kwang-Hoon Lee is associated with Yuhan Corporation, where he continues to advance his research in immunotherapy. His work has garnered attention for its potential impact on cancer treatment.

Collaborations

Kwang-Hoon Lee collaborates with notable colleagues, including June Hyung Lee and Na Rae Lee, to further enhance the development of innovative therapeutic solutions.

Conclusion

Kwang-Hoon Lee's contributions to the field of cancer treatment through his patented innovations highlight his role as a leading inventor in the biotechnology sector. His work continues to pave the way for advancements in cancer therapies.